| # | Drug | Count |
|---|---|---|
| 0 | PEMETREXED DISODIUM | 7 |
| 1 | ALPRAZOLAM | 6 |
| 2 | GEFITINIB | 6 |
| 3 | PEMETREXED | 6 |
| 4 | TACROLIMUS | 6 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 6 |
| 6 | TACROLIMUS OINTMENT 0.1% | 6 |
| 7 | CISPLATIN | 5 |
| 8 | DEXAMETHASONE | 4 |
| 9 | DEXAMETHASONE 1.5 MG | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GEFITINIB | 6 | 0.0007 |
| 1 | ERLOTINIB HYDROCHLORIDE | 4 | 0.0003 |
| 2 | AFATINIB | 2 | 0.0003 |
| 3 | GLATIRAMER ACETATE INJECTION | 1 | 0.0002 |
| 4 | PEMETREXED DISODIUM | 7 | 0.0002 |
| 5 | PRAZOSIN | 1 | 0.0002 |
| 6 | REGORAFENIB | 1 | 0.0001 |
| 7 | ACALABRUTINIB | 1 | 0.0001 |
| 8 | ROMOSOZUMAB-AQQG | 1 | 0.0001 |
| 9 | BICALUTAMIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Platinum-based Drug [EPC] | 7 | 0.0000 |
| 1 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 2 | Integrin Receptor Antagonist [EPC] | 2 | 0.0000 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 4 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Aromatase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 3 | 0.0000 |
| 7 | Kinase Inhibitor [EPC] | 9 | 0.0000 |
| 8 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 6 | 0.0000 |